ClinicalTrials.Veeva

Menu

The Effect of Insoluble Yeast Beta-glucan Intake on Pre-diabetic Patients

H

Huazhong University of Science and Technology

Status

Unknown

Conditions

Pre-diabetic

Treatments

Other: Placebo
Dietary Supplement: Yeast Beta-glucan

Study type

Interventional

Funder types

Other

Identifiers

NCT03495362
CHW20180201

Details and patient eligibility

About

There is a lot of evidence to show that the yeast beta-glucan has immunomodulatory, anti-inflammatory, anti-infective effects.However,few work was done on the relationship between yeast bata-glucan and the immune function of diabetic patients. This is a randomized double-blind trial, aiming to study the effect of yeast beta-glucan on immune system of prediabetic patients. Firstly, the investigators will go into the efficacy of yeast beta-glucan on improving the clinical symptoms of prediabetics. Secondly, the investigators will study the mechanism of yeast beta-glucan on enhancing the immune function and improving the inflammatory response.

Enrollment

52 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged between 18-65 years
  • Meet the pre-diabetes diagnostic criteria recommended by World Health Organization (WHO) in 1999

Exclusion criteria

  • Allergic to test substances
  • Known severe heart, liver, kidney, autoimmune diseases, psychosis, nervous system, hematopoietic system, endocrine and other systemic diseases
  • Known acute disease, common cold, metabolic diseases, chronic inflammation, infectious diseases, and heavy physical labor recently
  • Usage of antihyperlipidemia or antihypertension, and other drugs may influence the interventional effect last two weeks
  • Unable to cooperate with researchers or maintain ordinary dietary habit

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

52 participants in 2 patient groups, including a placebo group

Intervention group
Experimental group
Description:
Ingredients: yeast beta-glucan, and capsule shell Capsule, per capsule with 500mg insoluble beta-glucan, twice a day, 1 capsule each time. The intervention period is about 3 months.
Treatment:
Dietary Supplement: Yeast Beta-glucan
Placebo group
Placebo Comparator group
Description:
Ingredients: starch, and capsule shell Capsule, per capsule with 500mg starch, twice a day, 1 capsule each time. The intervention period is about 3 months.
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Liegang Liu, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems